Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe
Go back to Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe| (NASDAQ: MNPR) | Delayed: 70.65 -1.93 (2.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.58 | 52 Week High | $ | |||
| Open | $71.84 | 52 Week Low | $ | |||
| Day High | $71.84 | P/E | N/A | |||
| Day Low | $69.48 | EPS | $ | |||
| Volume | 96,757 | |||||



